Present Centered Psychotherapy for PTSD
(MERA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to help Veterans with PTSD (post-traumatic stress disorder) manage their emotions and reduce impulsive aggression, a common issue. It compares a new emotion regulation treatment, called Manage Emotions to Reduce Aggression (MERA), with a control group to determine if it better prepares Veterans for PTSD treatment. Veterans who have experienced combat since 9/11, have PTSD symptoms, and struggle with impulsive aggressive acts like yelling or hitting, might be a good fit for this study. The goal is to help Veterans improve their emotional coping skills and ultimately recover from PTSD. As an unphased trial, this study offers Veterans the opportunity to contribute to innovative research that could enhance PTSD treatment strategies.
Will I have to stop taking my current medications?
You won't have to stop taking your current medications, but you must agree not to change any psychotropic medications (medications that affect your mind, emotions, and behavior) during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Present Centered Psychotherapy (PCT) is generally safe and well-tolerated for treating PTSD. Studies have found that patients often continue with PCT treatment, possibly more than with some other therapies, suggesting it is manageable for most people.
Manage Emotions to Reduce Aggression (MERA) focuses on teaching skills to control emotions and reduce aggression. While specific safety data for MERA is unavailable, its emphasis on emotional management suggests it is likely low-risk. Both treatments aim to help Veterans better manage their emotions, potentially improving well-being.12345Why are researchers excited about this trial?
Researchers are excited about Present Centered Psychotherapy (PCT) and Manage Emotions to Reduce Aggression (MERA) for PTSD because these approaches focus on managing emotions and reducing aggression through concise therapy sessions. Unlike traditional PTSD treatments that often require long-term commitment, both PCT and MERA involve just three individual 90-minute sessions over three weeks, making them more accessible and time-efficient. Additionally, these therapies do not rely on medication, which can have side effects, but instead focus on improving emotional regulation and personal coping strategies. This could offer a promising alternative for individuals seeking effective, short-term treatment without the complications of pharmacotherapy.
What evidence suggests that this trial's treatments could be effective for PTSD?
Research has shown that the Manage Emotions to Reduce Aggression (MERA) program, one of the treatments in this trial, can help Veterans with PTSD by reducing aggression and improving emotional management. In a small initial study, Veterans who participated in MERA demonstrated a noticeable decrease in aggressive behavior and better emotional control, with a moderate impact measured by Cohen's d = -0.55.
Studies also indicate that Present Centered Psychotherapy (PCT), another treatment option in this trial, effectively reduces the severity of PTSD symptoms. PCT works well for Veterans and is often as effective as other trauma-focused therapies. Overall, both treatments in this trial have strong evidence supporting their ability to help manage PTSD symptoms.12567Who Is on the Research Team?
Shannon R. Miles, PhD
Principal Investigator
James A. Haley Veterans' Hospital, Tampa, FL
Are You a Good Fit for This Trial?
This trial is for Veterans who served since 9/11, have PTSD or subthreshold PTSD, and show impulsive aggression. They must not change their psychotropic medications during the study and need an independent observer to verify aggressive acts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 individual 90-minute sessions of either MERA or PCT over 3 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Assessment of Evidence Based Psychotherapy (EBP) initiation at 6 months posttreatment
What Are the Treatments Tested in This Trial?
Interventions
- Manage Emotions to Reduce Aggression
- Present Centered Psychotherapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
VA Boston Healthcare System
Collaborator
University of Houston
Collaborator
Texas A&M University
Collaborator
University of South Florida
Collaborator
Michael E. DeBakey VA Medical Center
Collaborator